| Data | Hora | Fonte | Título | Código | Companhia |
| 14/02/2017 | 21:15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 04/11/2016 | 18:03 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 31/10/2016 | 08:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 18:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 18:12 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 18:05 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 18:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 10:53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 09:57 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 25/10/2016 | 09:56 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 26/09/2016 | 17:50 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 26/09/2016 | 17:37 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 23/09/2016 | 17:31 | PR Newswire (US) | VITAE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vitae Pharmaceuticals, Inc. (VTAE) Over the Pro... | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 21/09/2016 | 17:44 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 15/09/2016 | 16:01 | Business Wire | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages ... | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 15/09/2016 | 11:43 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica... | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 21:15 | Business Wire | SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourag... | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 18:21 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Vitae Pharmaceuticals, Inc. | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 18:09 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 12:09 | Business Wire | VITAE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 10:40 | Dow Jones News | Allergan to Buy Vitae Pharmaceuticals for $639 Million | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 14/09/2016 | 09:00 | PR Newswire (US) | Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 01/09/2016 | 17:05 | GlobeNewswire Inc. | Vitae Pharmaceuticals to Present at Wells Fargo Healthcare Conference | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 15/08/2016 | 17:31 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 12/08/2016 | 17:32 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 11/08/2016 | 08:30 | GlobeNewswire Inc. | Vitae Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 10/08/2016 | 17:05 | GlobeNewswire Inc. | Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate Secretary | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 04/08/2016 | 17:11 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 03/08/2016 | 17:05 | GlobeNewswire Inc. | Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial Results | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 01/08/2016 | 18:30 | GlobeNewswire Inc. | Vitae Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 3, 2016 | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |